State Of Wisconsin Investment Board Biotechnology

State Of Wisconsin Investment Board

$37.8 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VRTX Vertex Pharmaceuticals Inc	$104B	$71.7 Million 0.19% of portfolio	154,179	Q3 2024 Added 3.3%
REGN Regeneron Pharmaceuticals, Inc.	$76.7B	$67.5 Million 0.18% of portfolio	64,176	Q3 2024 Added 11.74%
ALNY Alnylam Pharmaceuticals, Inc.	$28.9B	$21.8 Million 0.06% of portfolio	79,094	Q3 2024 Added 1.49%
MRNA Moderna, Inc.	$16.4B	$14 Million 0.04% of portfolio	209,964	Q3 2024 Added 0.39%
UTHR United Therapeutics Corp	$16.1B	$12 Million 0.03% of portfolio	33,401	Q3 2024 Added 28.0%
TECH Bio Techne Corp	$2.83B	$10.3 Million 0.03% of portfolio	128,319	Q3 2024 Added 2.35%
BMRN Biomarin Pharmaceutical Inc	$12.2B	$9.9 Million 0.03% of portfolio	140,894	Q3 2024 Added 7.88%
INCY Incyte Corp	$15.4B	$9.83 Million 0.03% of portfolio	148,680	Q3 2024 Reduced 5.71%
MRUS Merus N.V.	$1.93B	$8.32 Million 0.02% of portfolio	166,518	Q3 2024 Added 8.81%
PCVX Vaxcyte, Inc.	$4.94B	$8.26 Million 0.02% of portfolio	72,316	Q3 2024 Added 19.79%
INSM Insmed Inc	$9.35B	$7.98 Million 0.02% of portfolio	109,325	Q3 2024 Added 5.9%
SRPT Sarepta Therapeutics, Inc.	$10.6B	$7.23 Million 0.02% of portfolio	57,860	Q3 2024 Reduced 11.5%
RPRX Royalty Pharma PLC	$11.2B	$6.14 Million 0.02% of portfolio	216,965	Q3 2024 Added 7.82%
EXEL Exelixis, Inc.	$10.7B	$5.3 Million 0.01% of portfolio	204,325	Q3 2024 Reduced 7.66%
CORT Corcept Therapeutics Inc	$5.4B	$5.06 Million 0.01% of portfolio	109,280	Q3 2024 Reduced 10.94%
HALO Halozyme Therapeutics, Inc.	$6.66B	$4.99 Million 0.01% of portfolio	87,219	Q3 2024 Reduced 1.95%
VKTX Viking Therapeutics, Inc.	$3.09B	$4.73 Million 0.01% of portfolio	74,730	Q3 2024 Reduced 9.72%
JAZZ Jazz Pharmaceuticals PLC	$7.72B	$4.63 Million 0.01% of portfolio	41,544	Q2 2024 Added 25.59%
TGTX Tg Therapeutics, Inc.	$4.37B	$4.51 Million 0.01% of portfolio	192,975	Q3 2024 Reduced 17.73%
CYTK Cytokinetics Inc	$4.43B	$4.5 Million 0.01% of portfolio	85,249	Q3 2024 Reduced 1.81%
BPMC Blueprint Medicines Corp	$5.21B	$4.38 Million 0.01% of portfolio	47,323	Q3 2024 Reduced 7.97%
KRYS Krystal Biotech, Inc.	$4.02B	$4.19 Million 0.01% of portfolio	23,068	Q3 2024 Reduced 8.86%
ADMA Adma Biologics, Inc.	$3.37B	$4.14 Million 0.01% of portfolio	207,321	Q3 2024 Added 32.99%
CPRX Catalyst Pharmaceuticals, Inc.	$2.15B	$4.04 Million 0.01% of portfolio	203,470	Q3 2024 Reduced 13.77%
XENE Xenon Pharmaceuticals Inc.	$2.44B	$3.97 Million 0.01% of portfolio	100,982	Q3 2024 Added 12.45%
ACAD Acadia Pharmaceuticals Inc	$2.97B	$3.67 Million 0.01% of portfolio	238,554	Q3 2024 Reduced 1.68%
RARE Ultragenyx Pharmaceutical Inc.	$2.95B	$3.63 Million 0.01% of portfolio	65,266	Q3 2024 Reduced 7.52%
RVMD Revolution Medicines, Inc.	$3.84B	$3.53 Million 0.01% of portfolio	77,849	Q3 2024 Reduced 7.42%
FOLD Amicus Therapeutics, Inc.	$2.64B	$3.49 Million 0.01% of portfolio	326,323	Q3 2024 Reduced 6.72%
IONS Ionis Pharmaceuticals Inc	$4.96B	$3.45 Million 0.01% of portfolio	86,166	Q3 2024 Reduced 1.75%
CRNX Crinetics Pharmaceuticals, Inc.	$2.77B	$3.34 Million 0.01% of portfolio	65,394	Q3 2024 Added 8.24%
RNA Avidity Biosciences, Inc.	$1.52B	$3.32 Million 0.01% of portfolio	72,368	Q3 2024 Added 91.04%
VCEL Vericel Corp	$2.59B	$3.27 Million 0.01% of portfolio	77,408	Q3 2024 Reduced 3.8%
ROIV Roivant Sciences Ltd.	$8.33B	$2.88 Million 0.01% of portfolio	249,262	Q2 2024 Added 22.99%
LGND Ligand Pharmaceuticals Inc	$1.81B	$2.86 Million 0.01% of portfolio	28,550	Q3 2024 Reduced 17.8%
HRMY Harmony Biosciences Holdings, Inc.	$2.04B	$2.77 Million 0.01% of portfolio	69,330	Q3 2024 Added 1.32%
NUVL Nuvalent, Inc.	$3.36B	$2.75 Million 0.01% of portfolio	26,892	Q3 2024 Reduced 13.81%
AUPH Aurinia Pharmaceuticals Inc.	$1.27B	$2.71 Million 0.01% of portfolio	369,996	Q3 2024 Reduced 11.26%
CRSP Crispr Therapeutics Ag	$3.23B	$2.54 Million 0.01% of portfolio	53,989	Q3 2024 Reduced 2.32%
ACLX Arcellx, Inc.	$3.43B	$2.53 Million 0.01% of portfolio	30,240	Q3 2024 Reduced 22.79%
DNLI Denali Therapeutics Inc.	$2.73B	$2.37 Million 0.01% of portfolio	81,451	Q3 2024 Added 5.88%
INVA Innoviva, Inc.	$1.21B	$2.35 Million 0.01% of portfolio	121,587	Q3 2024 Added 19.44%
APLS Apellis Pharmaceuticals, Inc.	$3.51B	$2.34 Million 0.01% of portfolio	81,039	Q3 2024 Added 4.77%
AXSM Axsome Therapeutics, Inc.	$3.63B	$2.28 Million 0.01% of portfolio	25,358	Q3 2024 Added 8.56%
OMGA Omega Therapeutics, Inc.	$35.9M	$2.27 Million 0.01% of portfolio	1,857,265	Q3 2023 Reduced 0.1%
MNKD Mannkind Corp	$1.65B	$2.26 Million 0.01% of portfolio	360,564	Q3 2024 Added 104.51%
PTGX Protagonist Therapeutics, Inc	$1.89B	$2.12 Million 0.01% of portfolio	47,160	Q3 2024 Reduced 15.71%
MRVI Maravai Lifesciences Holdings, Inc.	$717M	$2.03 Million 0.01% of portfolio	244,537	Q3 2024 Added 246.8%
DYN Dyne Therapeutics, Inc.	$1.22B	$1.98 Million 0.01% of portfolio	55,103	Q3 2024 Added 6.89%
MIRM Mirum Pharmaceuticals, Inc.	$1.52B	$1.94 Million 0.01% of portfolio	49,734	Q3 2024 Reduced 11.92%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.